C2N Diagnostics News and Resources

C2N Diagnostics has announced a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corporation. The funding will support C2N’s efforts to expand its clinical laboratory services and advanced diagnostic solutions in brain health, particularly